GlassScriptPhysician profile
Stephen P Prater
NPI 1821097296
$10,722.28
in general payments reported to CMS, 2019-2025
38 companies · $1,281 in 2025
The $1,281 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,164 · 2020: $503 · 2021: $1,333 · 2022: $1,455 · 2023: $1,744 · 2024: $3,241 · 2025: $1,281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,178 · Travel and Lodging: $1,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,178.04 |
| Travel and Lodging | $1,089.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,783.93 | 2019-2025 | Aveir, Jot Dx, Tendril |
| Boston Scientific Corporation | $1,835.10 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Medtronic, INC. | $1,194.26 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Pulseselect |
| Pfizer INC. | $830.16 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $784.21 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $455.60 | 2019-2024 | |
| Amgen INC. | $393.69 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $344.18 | 2022-2025 | Verquvo, Winrevair |
| Biosense Webster, INC. | $342.30 | 2019-2025 | Carto 3 |
| Janssen Pharmaceuticals, INC | $269.26 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $191.03 | 2020-2025 | Farxiga, Wainua |
| Sanofi-Aventis U.S. LLC | $140.43 | 2019-2024 | |
| Medtronic Vascular, INC. | $88.26 | 2019-2020 | |
| Bridgebio Pharma, INC. | $80.99 | 2025 | Attruby |
| Impulse Dynamics (USA) INC. | $80.84 | 2022-2024 | Optimizer, Optimizer |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $79.36 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Elutia, INC. | $77.71 | 2019-2020 | |
| Philips North America LLC | $73.34 | 2022-2024 | (5044) Mcot |
| Braemar Manufacturing, LLC | $58.50 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $57.03 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.94 | 2020-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $56.23 | 2020-2025 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $49.12 | 2024-2025 | |
| Angiodynamics, INC. | $47.60 | 2023 | Alphavac |
| Scpharmaceuticals INC. | $47.01 | 2023-2024 | |
| Novo Nordisk INC | $40.99 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Cvrx, INC. | $40.77 | 2023 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $32.58 | 2023-2025 | Opsumit, Uptravi |
| Atricure, INC. | $29.84 | 2023 | |
| Convatec INC. | $28.06 | 2022 | |
| Alnylam Pharmaceuticals INC. | $19.07 | 2025 | Amvuttra |
| Cardiva Medical, INC. | $18.49 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Biotronik INC. | $18.33 | 2019 | |
| Vital Connect, INC | $16.24 | 2024 | Vitalpatch Rtm |
| Regeneron Healthcare Solutions, INC. | $15.87 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $15.12 | 2022 | |
| Esperion Therapeutics, INC. | $15.06 | 2024 | Nexletol |
| Amarin Pharma, INC. | $14.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Prater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.